Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/A-86929> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- A-86929 abstract "A-86929 is a synthetic compound that acts as a selective dopamine receptor D1 agonist. It was developed as a possible treatment for Parkinson's disease, as well as for other applications such as treatment of cocaine addiction, but while it had reasonable efficacy in humans it also caused dyskinesias and has not been continued. It has mainly been used as its diacetate ester prodrug adrogolide (ABT-431), which has better bioavailability.".
- A-86929 iupacName "9,10-Dihydroxy-2-propyl-4,5,5a(R),6,7,11b(S)-hexahydrobenzo[f]thieno[2,3-c]quinoline".
- A-86929 thumbnail A-86929_structure.png?width=300.
- A-86929 wikiPageID "23699209".
- A-86929 wikiPageLength "5694".
- A-86929 wikiPageOutDegree "13".
- A-86929 wikiPageRevisionID "695718018".
- A-86929 wikiPageWikiLink Acetate.
- A-86929 wikiPageWikiLink Agonist.
- A-86929 wikiPageWikiLink Category:Catechols.
- A-86929 wikiPageWikiLink Category:Dopamine_agonists.
- A-86929 wikiPageWikiLink Category:Thiophenes.
- A-86929 wikiPageWikiLink Cocaine_dependence.
- A-86929 wikiPageWikiLink Dopamine_receptor.
- A-86929 wikiPageWikiLink Dopamine_receptor_D1.
- A-86929 wikiPageWikiLink Dyskinesia.
- A-86929 wikiPageWikiLink Ester.
- A-86929 wikiPageWikiLink Parkinsons_disease.
- A-86929 wikiPageWikiLink Prodrug.
- A-86929 wikiPageWikiLink File:Adrogolide_structure.png.
- A-86929 wikiPageWikiLinkText "A-86929".
- A-86929 imagefile "A-86929_structure.png".
- A-86929 imagesize "200".
- A-86929 iupacname "910".
- A-86929 verifiedfields "changed".
- A-86929 verifiedrevid "477346404".
- A-86929 watchedfields "changed".
- A-86929 wikiPageUsesTemplate Template:Cascite.
- A-86929 wikiPageUsesTemplate Template:Chembox.
- A-86929 wikiPageUsesTemplate Template:Chembox_Hazards.
- A-86929 wikiPageUsesTemplate Template:Chembox_Identifiers.
- A-86929 wikiPageUsesTemplate Template:Chembox_Properties.
- A-86929 wikiPageUsesTemplate Template:Chemspidercite.
- A-86929 wikiPageUsesTemplate Template:Dopaminergics.
- A-86929 wikiPageUsesTemplate Template:Ebicite.
- A-86929 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- A-86929 wikiPageUsesTemplate Template:Reflist.
- A-86929 wikiPageUsesTemplate Template:Stdinchicite.
- A-86929 subject Category:Catechols.
- A-86929 subject Category:Dopamine_agonists.
- A-86929 subject Category:Thiophenes.
- A-86929 hypernym Compound.
- A-86929 type Agent.
- A-86929 type ChemicalCompound.
- A-86929 type ChemicalSubstance.
- A-86929 type Drug.
- A-86929 type Agent.
- A-86929 type Agonist.
- A-86929 type Benzenediol.
- A-86929 type Catechol.
- A-86929 type Chemical.
- A-86929 type Drug.
- A-86929 type Heterocycle.
- A-86929 type Redirect.
- A-86929 type ChemicalObject.
- A-86929 type Thing.
- A-86929 type Q11173.
- A-86929 comment "A-86929 is a synthetic compound that acts as a selective dopamine receptor D1 agonist. It was developed as a possible treatment for Parkinson's disease, as well as for other applications such as treatment of cocaine addiction, but while it had reasonable efficacy in humans it also caused dyskinesias and has not been continued. It has mainly been used as its diacetate ester prodrug adrogolide (ABT-431), which has better bioavailability.".
- A-86929 label "A-86929".
- A-86929 sameAs Q262610.
- A-86929 sameAs ای-۸۶۹۲۹.
- A-86929 sameAs A-86929.
- A-86929 sameAs m.06zkwnn.
- A-86929 sameAs A-86929.
- A-86929 sameAs A-86929.
- A-86929 sameAs Q262610.
- A-86929 wasDerivedFrom A-86929?oldid=695718018.
- A-86929 depiction A-86929_structure.png.
- A-86929 isPrimaryTopicOf A-86929.